Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Clear-cell metastatic renal cell carcinoma × tivozanib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1

Interventions

tivozanib 1 Zoledronic Acid 1 Specimen Handling 1 Radiotherapy 1 Pluvicto 1 Ibandronic Acid 1 Diphosphonates 1 Denosumab 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07218692 2025-10-20

RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy

City of Hope Medical Center

Phase 2 Not yet recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡